カリフォルニア州における小細胞肺がんの臨床試験
カリフォルニア州内の拠点で、小細胞肺がんに関する36件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Los Angeles20件の研究
- Baldwin Park6件の研究
- Santa Monica5件の研究
- San Diego4件の研究
- San Francisco4件の研究
- Sacramento3件の研究
- Mountain View3件の研究
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of San Diego Moores Cancer Center, La Jolla
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of California - Los Angeles, Los Angeles
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- City of Hope National Medical Center, Duarte
- UC San Diego Medical Center - Encinitas, Encinitas
- City of Hope Lennar Foundation Cancer Center, Irvine
- 他9件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07476287A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- GSK Investigational Site, Los Angeles
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07099898A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Precision NextGen Oncology, Beverly Hills
- OPN Healthcare, Inc, Glendale
- University of Southern California, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 281322, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 281396, Irvine
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07365241A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- START Los Angeles, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07488676Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Beverly Hills Cancer Center, Beverly Hills
- City of Hope Cancer Center, Duarte
- University of California Irvine Medical Center, Orange
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
- Valkyrie Clinical Trials, Inc., Los Angeles
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07459634BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
- Los Alamitos Hematology/Oncology Medical Group, Glendale
- MemorialCare Todd Cancer Institute, Long Beach
- Valkyrie Clinical Trials, Los Angeles
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07625644A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- University of California San Diego, La Jolla
- UC Davis Comprehensive Cancer Center, Sacramento
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07218146AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Los Angeles
- Avenzo Therapeutics Recruiting Site, Los Angeles
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- University of California LA, Los Angeles
被験者募集中第1/2相
18歳〜100歳 · 全性別 · 2026/08/27更新 · NCT06726148A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- Precision NextGen Oncology and Research Center, Beverly Hills
- Cedars Sinai Medical Center, Los Angeles
- UCLA - David Geffen School of Medicine, Santa Monica
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/26更新 · NCT06892548Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
- University of Southern California, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/19更新 · NCT06922539A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- The Oncology Institute of Hope and Innovation, Long Beach
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06095505A Study of MGC026 in Participants With Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Clinical Research Providence Medical Foundation, Fullerton
- UCLA Hematology-Oncology, Los Angeles
- UCSF Mission Bay Mission Hall, San Francisco
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/06更新 · NCT06203210DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Valkyrie Clinical Trials, Los Angeles
- University of California San Francisco, San Francisco
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/23更新 · NCT05882058A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
- IP Address: City of Hope Investigational Drug Services(IDS), Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT06131840A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT05652686LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
- University of California, Davis, Sacramento
被験者募集中
18歳以上 · 全性別 · 2026/07/08更新 · NCT06103682Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
- University of Southern California, Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/26更新 · NCT06598306A Study of LY4175408 in Participants With Advanced Cancer
- Stanford Medicine Cancer Center, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT07046923Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- Start Lacn, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/10更新 · NCT07517198Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Beckman Research Institute of City of Hope, Duarte
- VA Medical Center, Fresno, Fresno
- Santa Clara Valley Medical Center, Fruitdale
- 他5件
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Loma Linda University Medical Center, Loma Linda
- Eisenhower Medical Center, Rancho Mirage
- University of California Davis Comprehensive Cancer Center, Sacramento
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/30更新 · NCT06769126Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/11更新 · NCT06681220Engagement of Veterans With Lung Cancer
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto
被験者募集中
18歳以上 · 全性別 · 2026/03/03更新 · NCT07219251VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Providence Medical Foundation (site 209), Santa Rosa
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles
被験者募集中第2相
全年齢 · 全性別 · 2025/11/17更新 · NCT05588388A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
- Zelgen Site 105, Orange
被験者募集中第1相
18歳〜75歳 · 全性別 · 2025/08/06更新 · NCT06592638A Multicenter Cancer Biospecimen Collection Study
- Curebase, San Francisco
被験者募集中観察研究
18歳以上 · 全性別 · 2025/03/12更新 · NCT04510129ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。